[Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].

Momoko Yokoi, Toshinori Kondo, Risa Shimizu, Keiichi Uchida, Shigeki Hayashi, Hirotake Nishimura, Eisei Kondo, Hideho Wada
{"title":"[Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].","authors":"Momoko Yokoi,&nbsp;Toshinori Kondo,&nbsp;Risa Shimizu,&nbsp;Keiichi Uchida,&nbsp;Shigeki Hayashi,&nbsp;Hirotake Nishimura,&nbsp;Eisei Kondo,&nbsp;Hideho Wada","doi":"10.11406/rinketsu.64.735","DOIUrl":null,"url":null,"abstract":"<p><p>A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells. The patient was diagnosed using G-CSF-producing myeloma and was treated with daratumumab, lenalidomide, and dexamethasone. Her treatment resulted in a very good partial response, with normalization of both serum G-CSF levels and neutrophil count. There have been a few cases of G-CSF -producing myeloma reported, and it has previously been reported as chronic neutrophilic leukemia with M proteinemia. According to previous reports, techniques such as serum G-CSF measurements, IHC with an anti-G-CSF antibody, and CSF3R gene mutation analysis are useful for differentiating G-CSF-producing myeloma. However, the clinical characteristics and long-term prognosis of G-CSF-producing myeloma remain unknown. Additional case gathering and investigations are required.</p>","PeriodicalId":6352,"journal":{"name":"[Rinsho ketsueki] The Japanese journal of clinical hematology","volume":"64 8","pages":"735-740"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"[Rinsho ketsueki] The Japanese journal of clinical hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11406/rinketsu.64.735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells. The patient was diagnosed using G-CSF-producing myeloma and was treated with daratumumab, lenalidomide, and dexamethasone. Her treatment resulted in a very good partial response, with normalization of both serum G-CSF levels and neutrophil count. There have been a few cases of G-CSF -producing myeloma reported, and it has previously been reported as chronic neutrophilic leukemia with M proteinemia. According to previous reports, techniques such as serum G-CSF measurements, IHC with an anti-G-CSF antibody, and CSF3R gene mutation analysis are useful for differentiating G-CSF-producing myeloma. However, the clinical characteristics and long-term prognosis of G-CSF-producing myeloma remain unknown. Additional case gathering and investigations are required.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[粒细胞集落刺激因子产生多发性骨髓瘤表现为中性粒细胞增多]。
一名71岁妇女主诉恶心和厌食。实验室检查显示明显的嗜中性粒细胞和免疫球蛋白A-kappa型M蛋白血症,骨髓检查显示浆细胞增多。血清粒细胞集落刺激因子(G-CSF)浓度高达160 pg/ml,集落刺激因子3受体(CSF3R)-T618I突变为阴性。使用抗g - csf抗体对骨髓标本进行免疫组化(IHC)分析,结果显示部分骨髓瘤细胞免疫阳性。患者被诊断为产生g - csf的骨髓瘤,并接受了达拉单抗、来那度胺和地塞米松的治疗。她的治疗产生了非常好的部分反应,血清G-CSF水平和中性粒细胞计数均恢复正常。有少数G-CSF产生骨髓瘤的病例报道,它以前被报道为慢性中性粒细胞白血病伴M蛋白血症。根据以前的报道,血清G-CSF测定、抗G-CSF抗体的免疫反应和CSF3R基因突变分析等技术对于鉴别产生G-CSF的骨髓瘤是有用的。然而,产生g- csf的骨髓瘤的临床特征和长期预后尚不清楚。需要进行更多的病例收集和调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Refractory esophageal stricture of esophageal mucous membrane pemphigoid after allogeneic hematopoietic stem cell transplantation]. [Successful delivery using interferon α for molecular relapse of chronic myeloid leukemia after interruption of tyrosine kinase inhibitor]. [Diffuse large B-cell lymphoma complicated with pancreatic fistula and peritonitis following initial chemotherapy]. [Autoimmune coagulation factor V/5 deficiency during chronic disseminated intravascular coagulation]. [Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1